LI Xue-qun, YAN Feng-hao, ZHONG Zhan-hua, et al. Discussion on Re-entry Detective Strategy for Unpaid Blood Donors with False-reactive Results in Huizhou[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(2): 194-197.
1 郭永建,姚凤兰,林授,等.HIV-1 和HCV核酸检测、血液处置和献血者屏蔽与归队指引( 上)[J].中国输血杂志,2011,24( 1) :79-85. 2 Li L,Xu T,Yang T,et al. Establishing a Reentry Procedure for HIV Screening Reactive Donors in China[J].Transfusion,2016,56(1):195-202. 3 杨涛,牛丽彬,李玲,等.抗-HCV酶免筛查反应性献血者确证策略研究[J].中国输血杂志,2016,29(1):13-16. 4 FDA.Guidance for industry. nucleic acid testing (NAT)for humanimmunodeficiency virus type 1 ( HIV-1 ) and hepatitis C virus(HCV):testing,product disposition,and donor deferral and reentry,2010-05[J]. 5 Philip K,Erica W.Can we improve the management of blood donorswith nonspecific reactivity in viral screening and confirmatory as-says?[J]. Transfus Med Rev,2005,19(1):58-65. 6 李金明.血液感染性疾病标志物筛检中应重视的若干问题[J].中华检验医学杂志,2005,28(6):569-571. 7 曾劲峰,郑欣,许晓绚.ELISA 检测与NAT 在血液筛查应用中的互补性研究[J].中国输血杂志,2011,24(1) :79-85. 8 VermeulenM,vanDrimmelenH,ColemanC.Mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplificationtest options in preventing transmission risk by window period and occult hepatitis B virus infections[J]. Transfusion,2014,54(10):2496-2504.